About Vovantis Laboratories
Vovantis Laboratories is a company based in Vadodara (India) founded in 2008. It operates as a B2B. The company has 138 employees. Vovantis Laboratories operates in a competitive market with competitors including Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
- Headquarter Vadodara, India
- Employees 138
- SectorsHealthcare
- Email••••••••
- Website vovantis.com
- Legal Name Vovantis Laboratories Private Limited
- Date of Incorporation 06 Oct, 2008
- Jurisdiction Vadodara, Gujarat, India
- Annual Revenue₹76.05 Cr
FY 2025 · +67% YoY
- Net Profit₹3.82 Cr
FY 2025 · 5% margin
- EBITDA₹12.12 Cr
FY 2025 · 16% margin
- Employee Count138
Associated legal entities of Vovantis Laboratories
Vovantis Laboratories operates through Vovantis Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vovantis Laboratories Private Limited CIN U24230GJ2008PTC055176 | Active | 06 Oct 2008 | Vadodara, Gujarat | ₹76.1 Cr | 138 | 5 | View details |
Board of directors of Vovantis Laboratories Private Limited (Vovantis Laboratories)
Vovantis Laboratories Private Limited is the primary company behind Vovantis Laboratories. The board of Vovantis Laboratories Private Limited currently have 4 directors; the longest-serving is Mohal Kartikeya Sarabhai, appointed in 2008. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mohal Kartikeya Sarabhai DIN 00334441 | Director | 06 Oct 2008 | 18 yrs | Vovantis Laboratories Private Limited |
| Vinayak Kamalakar Nayak DIN 06531234 | Director | 22 Aug 2013 | 13 yrs 1 mo | Vovantis Laboratories Private Limited |
| Sultan Abbas Reshamwala DIN 06504015 | Director | 22 Aug 2013 | 13 yrs 1 mo | Vovantis Laboratories Private Limited |
| Brijesh Khandelwal DIN 10302293 | Director | 09 Oct 2024 | 2 yrs | Vovantis Laboratories Private Limited |
Financials of Vovantis Laboratories
Figures of Vovantis Laboratories Private Limited, the primary company behind Vovantis Laboratories, for FY 2025. Revenue was ₹76.05 Cr (+67% year on year). Net profit was ₹3.82 Cr (5% margin). EBITDA was ₹12.12 Cr (16% margin). Revenue has grown at a compounded annual rate of +5% over three years and +19% over five years.
- ₹76.05 CrRevenue · FY 2025 · +67% YoY
- ₹3.82 CrNet profit · 5% margin
- ₹12.12 CrEBITDA · 16% margin
- ₹28.50 CrPaid-up capital
- 138Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vovantis Laboratories Private Limited are on its company page.
Detailed financial statements for Vovantis Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Vovantis Laboratories
Vovantis Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inventiahealthcare.com | 1985 | Mumbai, India | $42.49M | 980 | Oral solid drug delivery systems are manufactured and developed. | |
| zimlab.in | 1989 | Nagpur, India | $8.2M | 598 | Solid and semisolid dosage forms are developed and manufactured. | |
| zelgen.com | 2009 | Suzhou, China | $61.92M | – | Company developing small molecules & eukaryotic cell based recombinant protein drugs | |
| capsugel.com | 1875 | Morristown, United States | – | – | Dosage forms are delivered for preclinical, clinical, and commercial supply. | |
| adarepharmasolutions.com | 2015 | Lawrence Township, United States | – | 217 | CDMO manufacturing solid drugs | |
| cpc.com | 1971 | Hauppauge, United States | – | 27 | Product development, manufacturing and packaging services | |
| lotuspharm.com | 1966 | Taipei, Taiwan | – | – | Contract manufacturing for oral solid formulations is offered. | |
| halewoodlabs.com | 1984 | Ahmedabad, India | – | 348 | Provides contract manufacturing services for food, pharmaceuticals, and related products globally. | |
| glukembiocare.com | 2014 | Hyderabad, India | – | 234 | Manufactures pellets, micro-pellets, granules, and capsules for pharmaceutical and nutraceutical drugs. |
Detailed competitors of Vovantis Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Vovantis Laboratories
10 companies that operate in the same segment as Vovantis Laboratories (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vovantis Laboratories
Vovantis Laboratories was founded in 2008.
Vovantis Laboratories is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Vovantis Laboratories has 138 employees.
The primary company behind Vovantis Laboratories, Vovantis Laboratories Private Limited, reported revenue of ₹76.05 Cr for FY 2025, up 67% year on year.
Vovantis Laboratories develops and manufactures novel effervescent drug delivery systems through providing healthcare solutions, producing pharmaceutical products, drug development, and drug delivery systems. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Vovantis Laboratories's top competitors include Inventia Healthcare, Zim Labs and Lotus.
Vovantis Laboratories operates through Vovantis Laboratories Private Limited.
The legal entities of Vovantis Laboratories currently have 5 directors, including Brijesh Khandelwal, Sanjana Joshi, Vinayak Kamalakar Nayak and others.